|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0001675,
umls-concept:C0011849,
umls-concept:C0018850,
umls-concept:C0023981,
umls-concept:C0030705,
umls-concept:C0030956,
umls-concept:C0034656,
umls-concept:C0221500,
umls-concept:C0282460,
umls-concept:C0332307,
umls-concept:C0542341
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2007-5-8
|
|
pubmed:abstractText |
Aim of this trial was to test whether heat shock protein peptide DiaPep277 treatment in adult and paediatric patients with recent-onset type 1 diabetes (T1D) is safe and whether it can preserve endogenous insulin production.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Autoantibodies,
http://linkedlifedata.com/resource/pubmed/chemical/C-Peptide,
http://linkedlifedata.com/resource/pubmed/chemical/Chaperonin 60,
http://linkedlifedata.com/resource/pubmed/chemical/DiaPep 277,
http://linkedlifedata.com/resource/pubmed/chemical/HLA Antigens,
http://linkedlifedata.com/resource/pubmed/chemical/Hemoglobin A, Glycosylated,
http://linkedlifedata.com/resource/pubmed/chemical/Hypoglycemic Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Insulin,
http://linkedlifedata.com/resource/pubmed/chemical/Peptide Fragments,
http://linkedlifedata.com/resource/pubmed/chemical/Peptides
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
1520-7552
|
|
pubmed:author |
pubmed-author:BarkaiLászlóL,
pubmed-author:BattelinoTadejT,
pubmed-author:HosszufalusiNoraN,
pubmed-author:JermendyGyörgyG,
pubmed-author:KovácsPeterP,
pubmed-author:LengyelCsabaC,
pubmed-author:MadácsyLászlóL,
pubmed-author:MeierhoffGuidoG,
pubmed-author:OroszlánTamásT,
pubmed-author:PánczélPálP,
pubmed-author:SütöGáborG,
pubmed-author:SchlootNanette CNC,
pubmed-author:TakácsJózsefJ,
pubmed-author:VándorfiGyözöG
|
|
pubmed:copyrightInfo |
Copyright 2007 John Wiley & Sons, Ltd.
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
23
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
276-85
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:17103487-Adolescent,
pubmed-meshheading:17103487-Adult,
pubmed-meshheading:17103487-Autoantibodies,
pubmed-meshheading:17103487-C-Peptide,
pubmed-meshheading:17103487-Chaperonin 60,
pubmed-meshheading:17103487-Child,
pubmed-meshheading:17103487-Diabetes Mellitus, Type 1,
pubmed-meshheading:17103487-Dose-Response Relationship, Drug,
pubmed-meshheading:17103487-Double-Blind Method,
pubmed-meshheading:17103487-Drug Therapy, Combination,
pubmed-meshheading:17103487-HLA Antigens,
pubmed-meshheading:17103487-Hemoglobin A, Glycosylated,
pubmed-meshheading:17103487-Humans,
pubmed-meshheading:17103487-Hypoglycemic Agents,
pubmed-meshheading:17103487-Injections, Subcutaneous,
pubmed-meshheading:17103487-Insulin,
pubmed-meshheading:17103487-Insulin-Secreting Cells,
pubmed-meshheading:17103487-Islets of Langerhans,
pubmed-meshheading:17103487-Peptide Fragments,
pubmed-meshheading:17103487-Peptides
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Effect of heat shock protein peptide DiaPep277 on beta-cell function in paediatric and adult patients with recent-onset diabetes mellitus type 1: two prospective, randomized, double-blind phase II trials.
|
|
pubmed:affiliation |
German Diabetes Clinic, German Diabetes Center, Leibniz Institute at the Heinrich-Heine-University, Düsseldorf, Germany. schloot@ddz.uni-duesseldorf.de
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study,
Clinical Trial, Phase II
|
